Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '2550.0028.85

Profile

Edit
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
URL https://www.xenon-pharma.com
Investor Relations URL https://investor.xenon-pharma.com/
HQ State/Province British Columbia
Sector Health Care
Industry Biotechnology
Next Earnings Release Aug. 08, 2025 (est.)
Last Earnings Release May. 12, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
URL https://www.xenon-pharma.com
Investor Relations URL https://investor.xenon-pharma.com/
HQ State/Province British Columbia
Sector Health Care
Industry Biotechnology
Next Earnings Release Aug. 08, 2025 (est.)
Last Earnings Release May. 12, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows